Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2014

Open Access 01-12-2014 | Research article

Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E–knockout mice

Authors: Gang Li, Xiao-wei Wu, Wei-hua Lu, Rong Ai, Fang Chen, Zhong-zhi Tang

Published in: BMC Cardiovascular Disorders | Issue 1/2014

Login to get access

Abstract

Background

Gamma-glutamyl transpeptidase (GGT) is now considered to be one of the risk factors for cardiovascular disease. However, whether statins can alter GGT levels in arterial atheromatous plaque has not yet been studied. Therefore, the aim of this study is to determine whether statins can effectively decrease the expression of GGT in arterial atheromatous plaques.

Methods

We randomly divided 45 apolipoprotein E–knockout (ApoE KO) male mice into three groups: normal diet (ND) group,high-cholesterol diet (HCD) group and high-cholesterol diet and atorvastatin (HCD + Ato) group. We fed high-cholesterol food to the HCD and HCD + Ato group. After eight weeks, atorvastatin 5 mg•kg−1•d−1 was given to HCD + Ato group mice. The serum GGT-1, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell-adhesion molecule-1 (VCAM-1) levels were measured at end of 16 weeks by using ELISA methods. The expressions of GGT-1, ICAM-1 and VCAM-1 in aorta were measured by RT-PCR and Western Blot.

Results

The ApoE KO mice with HCD were associated with a marked increase in plasma lipid, inflammatory factors, GGT-1, ICAM-1 and VCAM-1. The expressions of GGT-1, ICAM-1 and VCAM-1 in HCD aortic tissue were increased. At the HCD + Ato group were treated with atorvastatin, the levels of lipid, GGT-1, ICAM-1 and VCAM-1were suppressed. Meanwhile, the expressions of GGT-1, ICAM-1 and VCAM-1 were significantly decreased in the whole aorta plaques.

Conclusions

The effect of statins on the expression of GGT in aorta plaque was firstly observed in animal model. The research shows that statins can significantly decrease the expression of GGT in aortic atherosclerotic plaques.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhao S, Yu B, Peng D, Huo Y: The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial. Atherosclerosis. 2014, 233: 707-712. 10.1016/j.atherosclerosis.2013.12.003.CrossRefPubMed Zhao S, Yu B, Peng D, Huo Y: The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial. Atherosclerosis. 2014, 233: 707-712. 10.1016/j.atherosclerosis.2013.12.003.CrossRefPubMed
2.
go back to reference Reiner Ž, De Bacquer D, Kotseva K, Prugger C, Backer De G, Wood D: Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey. Atherosclerosis. 2013, 231: 300-307. 10.1016/j.atherosclerosis.2013.09.020.CrossRefPubMed Reiner Ž, De Bacquer D, Kotseva K, Prugger C, Backer De G, Wood D: Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey. Atherosclerosis. 2013, 231: 300-307. 10.1016/j.atherosclerosis.2013.09.020.CrossRefPubMed
3.
go back to reference Athyros VG, Tziomalos K, Gossios TD, Griva T, Anagnostis P, Kargiotis K, Pagourelias ED, Theocharidou E, Karagiannis A, Mikhailidis DP: Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet. 2010, 376: 1916-1922. 10.1016/S0140-6736(10)61272-X.CrossRefPubMed Athyros VG, Tziomalos K, Gossios TD, Griva T, Anagnostis P, Kargiotis K, Pagourelias ED, Theocharidou E, Karagiannis A, Mikhailidis DP: Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet. 2010, 376: 1916-1922. 10.1016/S0140-6736(10)61272-X.CrossRefPubMed
4.
go back to reference Antoniades C, Bakogiannis C, Leeson P, Guzik TJ, Zhang MH, Tousoulis D, Antonopoulos AS, Demosthenous M, Marinou K, Hale A, Paschalis A, Psarros C, Triantafyllou C, Bendall J, Casadei B, Stefanadis C, Channon KM: Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation. 2011, 124: 335-345. 10.1161/CIRCULATIONAHA.110.985150.CrossRefPubMed Antoniades C, Bakogiannis C, Leeson P, Guzik TJ, Zhang MH, Tousoulis D, Antonopoulos AS, Demosthenous M, Marinou K, Hale A, Paschalis A, Psarros C, Triantafyllou C, Bendall J, Casadei B, Stefanadis C, Channon KM: Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation. 2011, 124: 335-345. 10.1161/CIRCULATIONAHA.110.985150.CrossRefPubMed
5.
go back to reference Schmidt-Lucke C, Fichtlscherer S, Rössig L, Kämper U, Dimmeler S: Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis. 2010, 211: 249-254. 10.1016/j.atherosclerosis.2010.02.007.CrossRefPubMed Schmidt-Lucke C, Fichtlscherer S, Rössig L, Kämper U, Dimmeler S: Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis. 2010, 211: 249-254. 10.1016/j.atherosclerosis.2010.02.007.CrossRefPubMed
6.
go back to reference Elewa HF, El‒Remessy AB, Somanath PR, Fagan SC: Diverse effects of statins on angiogenesis: new therapeutic avenues. Pharmacotherapy. J Human Pharmacol Drug Ther. 2010, 30: 169-176. 10.1592/phco.30.2.169.CrossRef Elewa HF, El‒Remessy AB, Somanath PR, Fagan SC: Diverse effects of statins on angiogenesis: new therapeutic avenues. Pharmacotherapy. J Human Pharmacol Drug Ther. 2010, 30: 169-176. 10.1592/phco.30.2.169.CrossRef
7.
go back to reference Jain MK, Ridker PM: Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005, 4: 977-987. 10.1038/nrd1901.CrossRefPubMed Jain MK, Ridker PM: Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005, 4: 977-987. 10.1038/nrd1901.CrossRefPubMed
8.
go back to reference Trialists CT: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010, 376: 1670-1681.CrossRef Trialists CT: Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010, 376: 1670-1681.CrossRef
9.
go back to reference Sampson UK, Fazio S, Linton MRF: Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep. 2012, 14: 1-10. 10.1007/s11883-011-0219-7.CrossRefPubMedPubMedCentral Sampson UK, Fazio S, Linton MRF: Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep. 2012, 14: 1-10. 10.1007/s11883-011-0219-7.CrossRefPubMedPubMedCentral
10.
go back to reference Mason JE, Starke RD, Van Kirk JE: Gamma‒Glutamyl transferase: a novel cardiovascular risk BioMarker. Prev Cardiol. 2010, 13: 36-41. 10.1111/j.1751-7141.2009.00054.x.CrossRefPubMed Mason JE, Starke RD, Van Kirk JE: Gamma‒Glutamyl transferase: a novel cardiovascular risk BioMarker. Prev Cardiol. 2010, 13: 36-41. 10.1111/j.1751-7141.2009.00054.x.CrossRefPubMed
11.
go back to reference Gül M, Uyarel H, Ergelen M, Ekmekci A, Özal E, Murat A, Kul S, Çelik O, Karaca G, Akturk F, Eksik A: The relationship between gamma glutamyl transferase levels and the clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary PCI. J Am Coll Cardiol. 2013, 62: C215-C215.CrossRef Gül M, Uyarel H, Ergelen M, Ekmekci A, Özal E, Murat A, Kul S, Çelik O, Karaca G, Akturk F, Eksik A: The relationship between gamma glutamyl transferase levels and the clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary PCI. J Am Coll Cardiol. 2013, 62: C215-C215.CrossRef
12.
go back to reference Grundy SM: Gamma-glutamyl transferase another biomarker for metabolic syndrome and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2007, 27: 4-7. 10.1161/01.ATV.0000253905.13219.4b.CrossRefPubMed Grundy SM: Gamma-glutamyl transferase another biomarker for metabolic syndrome and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2007, 27: 4-7. 10.1161/01.ATV.0000253905.13219.4b.CrossRefPubMed
13.
go back to reference Lee DH, Blomhoff R, Jacobs DR: Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res. 2004, 38: 535-539. 10.1080/10715760410001694026.CrossRefPubMed Lee DH, Blomhoff R, Jacobs DR: Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res. 2004, 38: 535-539. 10.1080/10715760410001694026.CrossRefPubMed
14.
go back to reference Giral P, Ratziu V, Couvert P, CarriR A, Kontush A, Girerd X, Chapman MJ: Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: relevance to oxidative stress. Atherosclerosis. 2010, 210: 607-613. 10.1016/j.atherosclerosis.2009.12.026.CrossRefPubMed Giral P, Ratziu V, Couvert P, CarriR A, Kontush A, Girerd X, Chapman MJ: Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: relevance to oxidative stress. Atherosclerosis. 2010, 210: 607-613. 10.1016/j.atherosclerosis.2009.12.026.CrossRefPubMed
15.
go back to reference Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, Pompella A: Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation. 2004, 109: 1440-10.1161/01.CIR.0000120558.41356.E6.CrossRefPubMed Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, Pompella A: Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation. 2004, 109: 1440-10.1161/01.CIR.0000120558.41356.E6.CrossRefPubMed
16.
go back to reference Reagan-Shaw S, Nihal M, Ahmad N: Dose translation from animal to human studies revisited. FASEB J. 2007, 22: 659-661. 10.1096/fj.07-9574LSF.CrossRefPubMed Reagan-Shaw S, Nihal M, Ahmad N: Dose translation from animal to human studies revisited. FASEB J. 2007, 22: 659-661. 10.1096/fj.07-9574LSF.CrossRefPubMed
17.
go back to reference Emdin M, Pompella A, Paolicchi A: Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease triggering oxidative stress within the plaque. Circulation. 2005, 112: 2078-2080. 10.1161/CIRCULATIONAHA.105.571919.CrossRefPubMed Emdin M, Pompella A, Paolicchi A: Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease triggering oxidative stress within the plaque. Circulation. 2005, 112: 2078-2080. 10.1161/CIRCULATIONAHA.105.571919.CrossRefPubMed
18.
go back to reference Galli E, Mariani M, Botto N, Paradossi U, Cardullo S, Taddei A, Storti S, Clerico A, Emdin M, Berti S, Galli E: Gamma-glutamyltransferase levels as a predictor of mortality in patients with ST-elevation myocardial infarction. Eur Heart J. 2013, 34: P5565-CrossRef Galli E, Mariani M, Botto N, Paradossi U, Cardullo S, Taddei A, Storti S, Clerico A, Emdin M, Berti S, Galli E: Gamma-glutamyltransferase levels as a predictor of mortality in patients with ST-elevation myocardial infarction. Eur Heart J. 2013, 34: P5565-CrossRef
19.
go back to reference Du G, Song Z, Zhang Q: Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies. Prev Med. 2013, 57: 31-37. 10.1016/j.ypmed.2013.03.011.CrossRefPubMed Du G, Song Z, Zhang Q: Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies. Prev Med. 2013, 57: 31-37. 10.1016/j.ypmed.2013.03.011.CrossRefPubMed
20.
go back to reference Maria F, Alessandro C, Barbara M, Antonella DC: γ-Glutamyltransferase activity in human atherosclerotic plaques—biochemical similarities with the circulating enzyme. Atherosclerosis. 2009, 202: 119-127. 10.1016/j.atherosclerosis.2008.03.023.CrossRef Maria F, Alessandro C, Barbara M, Antonella DC: γ-Glutamyltransferase activity in human atherosclerotic plaques—biochemical similarities with the circulating enzyme. Atherosclerosis. 2009, 202: 119-127. 10.1016/j.atherosclerosis.2008.03.023.CrossRef
21.
go back to reference Demircan S, Yazici M, Durna K, Kilicaslan F, Demir S, Pinar M, Gulel O: The importance of gamma glutamyltransferase activity in patients with coronary artery disease. Clin Cardiol. 2009, 32: 220-225. 10.1002/clc.20345.CrossRefPubMed Demircan S, Yazici M, Durna K, Kilicaslan F, Demir S, Pinar M, Gulel O: The importance of gamma glutamyltransferase activity in patients with coronary artery disease. Clin Cardiol. 2009, 32: 220-225. 10.1002/clc.20345.CrossRefPubMed
22.
go back to reference Aksakal E, Tanboga IH, Kurt M, Kaygyg MA, Kaya A, Isik T, Ekinci M, Sevimli S, Acikel M: The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease. Atherosclerosis. 2012, 221: 596-601. 10.1016/j.atherosclerosis.2012.01.044.CrossRefPubMed Aksakal E, Tanboga IH, Kurt M, Kaygyg MA, Kaya A, Isik T, Ekinci M, Sevimli S, Acikel M: The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease. Atherosclerosis. 2012, 221: 596-601. 10.1016/j.atherosclerosis.2012.01.044.CrossRefPubMed
23.
go back to reference Cakar M, Balta S, Demirkol S, Altun B, Demirbas S: Serum gamma-glutamyltransferase (GGT) should be evaluated together with other inflammatory markers in clinical practice. Angiology. 2013, 64: 401-401. 10.1177/0003319712469876.CrossRefPubMed Cakar M, Balta S, Demirkol S, Altun B, Demirbas S: Serum gamma-glutamyltransferase (GGT) should be evaluated together with other inflammatory markers in clinical practice. Angiology. 2013, 64: 401-401. 10.1177/0003319712469876.CrossRefPubMed
24.
go back to reference Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, Malvaldi G, Pompella A: β-Lipoprotein- and LDL-associated serum γ-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis. 2006, 186: 80-85. 10.1016/j.atherosclerosis.2005.07.012.CrossRefPubMed Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, Malvaldi G, Pompella A: β-Lipoprotein- and LDL-associated serum γ-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis. 2006, 186: 80-85. 10.1016/j.atherosclerosis.2005.07.012.CrossRefPubMed
25.
go back to reference Sun J, Ren J, Pang ZC, Gao WG, Nan HR, Wang SJ, Zhang L, Qiao Q: The association of gamma-glutamyltransferase and C-reactive protein with IFG/IGT in Chinese adults in Qingdao, China. Clin Chim Acta. 2011, 412: 1658-1661. 10.1016/j.cca.2011.05.019.CrossRefPubMed Sun J, Ren J, Pang ZC, Gao WG, Nan HR, Wang SJ, Zhang L, Qiao Q: The association of gamma-glutamyltransferase and C-reactive protein with IFG/IGT in Chinese adults in Qingdao, China. Clin Chim Acta. 2011, 412: 1658-1661. 10.1016/j.cca.2011.05.019.CrossRefPubMed
26.
go back to reference Bradley RD, Fitzpatrick AL, Jacobs DR, Lee DH, Jenny NS, Herrington D: Associations between γ-glutamyltransferase (GGT) and biomarkers of atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis. 2014, 233: 387-393. 10.1016/j.atherosclerosis.2014.01.010.CrossRefPubMedPubMedCentral Bradley RD, Fitzpatrick AL, Jacobs DR, Lee DH, Jenny NS, Herrington D: Associations between γ-glutamyltransferase (GGT) and biomarkers of atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis. 2014, 233: 387-393. 10.1016/j.atherosclerosis.2014.01.010.CrossRefPubMedPubMedCentral
28.
go back to reference Schmitz B, Vischer P, Brand E, Schmidt-Petersen K, Korb-Pap A, Guske K, Nedele J, Schelleckes M, Hillen J, Rötrige A, Simmet T, Paul M, Cambien F, Brand SM: Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro. Atherosclerosis. 2013, 230: 185-190. 10.1016/j.atherosclerosis.2013.07.039.CrossRefPubMed Schmitz B, Vischer P, Brand E, Schmidt-Petersen K, Korb-Pap A, Guske K, Nedele J, Schelleckes M, Hillen J, Rötrige A, Simmet T, Paul M, Cambien F, Brand SM: Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro. Atherosclerosis. 2013, 230: 185-190. 10.1016/j.atherosclerosis.2013.07.039.CrossRefPubMed
29.
go back to reference Yang JCS, Huang F, Wu CJ, Chen YC, Lu TH, Hsieh CH: Simvastatin reduces VCAM-1 expression in human umbilical vein endothelial cells exposed to lipopolysaccharide. Inflamm Res. 2012, 61: 485-491. 10.1007/s00011-012-0435-9.CrossRefPubMed Yang JCS, Huang F, Wu CJ, Chen YC, Lu TH, Hsieh CH: Simvastatin reduces VCAM-1 expression in human umbilical vein endothelial cells exposed to lipopolysaccharide. Inflamm Res. 2012, 61: 485-491. 10.1007/s00011-012-0435-9.CrossRefPubMed
30.
go back to reference Chung HK, Lee IK, Kang H, Suh JM, Kim H, Park KC, Kim DW, Kim YK, Ro HK, Shong MH: Statin inhibits interferon-γ-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells. Exp Mol Med. 2002, 34: 451-461. 10.1038/emm.2002.63.CrossRefPubMed Chung HK, Lee IK, Kang H, Suh JM, Kim H, Park KC, Kim DW, Kim YK, Ro HK, Shong MH: Statin inhibits interferon-γ-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells. Exp Mol Med. 2002, 34: 451-461. 10.1038/emm.2002.63.CrossRefPubMed
Metadata
Title
Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E–knockout mice
Authors
Gang Li
Xiao-wei Wu
Wei-hua Lu
Rong Ai
Fang Chen
Zhong-zhi Tang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2014
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-14-145

Other articles of this Issue 1/2014

BMC Cardiovascular Disorders 1/2014 Go to the issue